Active Filters

  • (-) Publication Year = 2021
  • (-) Publication Types = Journal Article
  • (-) Collection = *:external
  • (-) Keywords = CDK12/13
Search Results 1 - 1 of 1
  • RSS Feed
Select Page
Structure-activity relationship study of THZ531 derivatives enables the discovery of BSJ-01-175 as a dual CDK12/13 covalent inhibitor with efficacy in Ewing sarcoma
Jiang, B., Jiang, J., Kaltheuner, I. H., Iniguez, A. B., Anand, K., Ferguson, F. M., … Gray, N. S. (2021). Structure-activity relationship study of THZ531 derivatives enables the discovery of BSJ-01-175 as a dual CDK12/13 covalent inhibitor with efficacy in Ewing sarcoma. European Journal of Medicinal Chemistry, 221, 113481 (16 pp.). https://doi.org/10.1016/j.ejmech.2021.113481